Digital therapy for chronic back pain
Official title: Healing Track Randomized Clinical Trial
Run by Icahn School of Medicine at Mount Sinai · NCT06641102 · Data updated 2026-11-12
This study is testing a new digital therapy for chronic back pain to see if it works better than regular treatments for helping people feel less pain.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 21 Years to 70 Years |
| Sex | All |
| Enrollment | 180 (estimated) |
| Sponsor | Icahn School of Medicine at Mount Sinai Academic / other |
| Locations | 1 site (New York, New York) |
| Status | Recruiting |
| Started | May 12, 2025 |
| Main results expected | March 31, 2027 |
| Study ends | March 31, 2027 |
| Registry record updated | October 28, 2026 |
| Trial ID | NCT06641102 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 21 to 70 who have been experiencing chronic back pain for at least three months.
✕Probably not a fit
Patients with back pain related to compensation or litigation issues, or those whose leg pain is greater than their back pain, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial evaluates a digital pain reprocessing therapy (PRT) for individuals suffering from chronic back pain (CBP). Participants will be randomized into three groups: one receiving a self-guided digital program, another receiving a coach-assisted program, and a control group receiving standard of care interventions. The study aims to compare the effectiveness of the digital therapy against traditional treatment methods in reducing pain intensity. A total of 180 adults aged 21 to 70 with chronic back pain will be enrolled in the trial.
Why it matters
Potential benefit: If successful, this digital therapy could provide a more effective and accessible treatment option for patients with chronic back pain.
How similar studies have gone: Other studies have shown promise in using digital therapies for pain management, suggesting potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged 21 to 70 * Chronic Back Pain- CBP will be defined according to the criteria established by a recent NIH task force * Pain duration must be at least 3 months, with back pain being an ongoing problem for at least half the days of the last 6 months. That is, patients can meet criteria by either reporting pain every day for the past 3 months, or by reporting pain on half or more of the days for the past 6+ months. * Patients must rate pain intensity at 4/10 or greater on the Brief Pain Inventory-Short Form (BPISF) (on the item measuring average pain over the last week). * Participants must also be comfortable and able to communicate via email or text message, as several study measures are collected in this manner. * Able to use a smartphone Exclusion Criteria: * Back pain associated with compensation or litigation issues as determined by self-report within the past year * Leg pain is greater than back pain, as this suggests neuropathic pain, which may be less responsive to psychotherapy * Cauda Equina syndrome, as screened for by self-reported inability to control bowel or bladder function * Self-reported diagnoses of schizophrenia, multiple personality disorder, or dissociative identity disorder * Self-reported use of intravenous drugs, due to concerns about infections and subject compliance with experimental protocols
Where it's running
-
Icahn School of Medicine at Mount Sinai - Abilities Research Center
New York, New York, United States Recruiting
Study contacts
- Principal investigator: David Putrino, PhD — Icahn School of Medicine at Mount Sinai
- Study coordinator: Mackenzie Doerstling, MPH
- Email: CoreResearch@mountsinai.org
- Phone: (212) 241-8454
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Validation of the 2025 Axial Spondyloarthritis Classification Criteria in Chinese patients
This study tests whether the 2025 ASAS-SPARTAN criteria correctly classify axial spondyloarthritis in adults with chronic back pain in China.
-
Basivertebral Nerve Ablation for Axial Low Back Pain
This trial tests whether monopolar basivertebral nerve ablation can reduce pain for adults with chronic axial low back pain who have certain MRI changes and have not benefited enough from other treatments.
-
Percutaneous ear (auricular) vagus nerve stimulation plus standard rehabilitation for chronic back pain
This will try adding tiny electrical stimulation to the outer ear (pVNS) alongside standard rehabilitation to see if adults with chronic back pain have less pain and better function.
-
Sedation before ultrasound-guided spinal anesthesia to reduce back pain after surgery.
This trial will test whether giving midazolam before ultrasound-guided spinal anesthesia lowers the chance of new or persistent back pain after elective lower abdominal or leg surgery in adults.
-
Using focused ultrasound to treat chronic pain
This study is testing if low-intensity focused ultrasound can help people with chronic back pain feel less pain by targeting a specific part of the brain.
-
Using focused ultrasound to treat pain, anxiety, and opioid cravings
This study is testing whether a new ultrasound treatment can help people with opioid use disorder, chronic back pain, and anxiety feel less pain, reduce anxiety, and curb cravings for opioids.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.